{"result": "\n{\n    \"title\": \"ARDS and the ROSE Trial Community\",\n    \"summary\": \"The community is centered around Acute Respiratory Distress Syndrome (ARDS) and the ROSE trial, which investigates the efficacy of early neuromuscular blockade in ARDS patients. Key entities include the use of Cisatracurium, the SOFA score for assessing organ failure, and various treatment strategies like prone positioning and PEEP. The community is interconnected through clinical trials and studies aimed at improving ARDS treatment outcomes.\",\n    \"rating\": 8.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the critical nature of ARDS and the significant implications of the ROSE trial on treatment protocols.\",\n    \"findings\": [\n        {\n            \"summary\": \"Significance of ARDS in the community\",\n            \"explanation\": \"Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition that is central to this community. It is characterized by rapid onset and requires intensive medical intervention, often involving mechanical ventilation and intensive care. ARDS is a primary focus of the ROSE trial, which aims to improve treatment outcomes for patients suffering from this condition [Data: Entities (91); Relationships (309, 387, 388, 389, 402, +more)].\"\n        },\n        {\n            \"summary\": \"Role of the ROSE trial\",\n            \"explanation\": \"The ROSE trial is a pivotal study conducted by the PETAL Clinical Trials Network to assess the efficacy and safety of early neuromuscular blockade in ARDS patients. This multicenter, unblinded, randomized trial evaluates the use of Cisatracurium as a neuromuscular blocking agent, comparing its effects on 90-day mortality against a placebo group. The trial's findings are crucial for determining the best practices in ARDS management [Data: Entities (190, 192); Relationships (386, 382, 487, 621, +more)].\"\n        },\n        {\n            \"summary\": \"Cisatracurium's impact on ARDS treatment\",\n            \"explanation\": \"Cisatracurium is a neuromuscular blocking agent used in the ROSE trial as part of the intervention group for ARDS patients. The study aims to evaluate its effect on 90-day mortality, with the drug being administered as an early continuous infusion to improve survival rates and reduce barotrauma. However, there was one death in the trial possibly related to its use, highlighting the need for careful consideration of its risks and benefits [Data: Entities (89, 202); Relationships (376, 273, 383, 382, +more)].\"\n        },\n        {\n            \"summary\": \"Use of the SOFA score in assessing patient outcomes\",\n            \"explanation\": \"The Sequential Organ Failure Assessment (SOFA) score is a comprehensive scoring system used to track a patient's status, particularly focusing on organ function and the rate of organ failure. In the context of ARDS, the SOFA score is employed to assess the severity of organ dysfunction and predict outcomes. It is a critical tool in the ROSE trial and other studies to monitor patient progress and evaluate treatment efficacy [Data: Entities (145, 207); Relationships (389, 331, 636, 635, +more)].\"\n        },\n        {\n            \"summary\": \"Prone positioning as a treatment strategy\",\n            \"explanation\": \"Prone positioning is a medical intervention where patients are placed face down to improve oxygenation and reduce lung injury in ARDS patients. This technique has been shown to enhance outcomes in patients with severe ARDS by improving lung function and survival rates. It is a key component of the treatment strategies evaluated in the ROSE trial and other related studies [Data: Entities (579); Relationships (402, 339, 1004, 1007, +more)].\"\n        },\n        {\n            \"summary\": \"PEEP strategy in ARDS management\",\n            \"explanation\": \"Positive End-Expiratory Pressure (PEEP) is a ventilation parameter used in the treatment of ARDS to improve oxygenation and reduce mortality. The PEEP strategy is employed in the ROSE trial to assess its effectiveness in enhancing patient outcomes. It is a critical component of the ventilation strategies used in managing ARDS, alongside other interventions like prone positioning [Data: Entities (204, 212); Relationships (395, 399, 632, +more)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n91,ARDS,\"Acute Respiratory Distress Syndrome (ARDS) is a severe lung condition characterized by rapid onset of widespread inflammation in the lungs, leading to respiratory failure. It is marked by hypoxemia, decreased lung compliance, and bilateral alveolar opacities. ARDS requires intensive medical intervention, often necessitating mechanical ventilation support and intensive care. This condition was a criterion for patient inclusion in a study, with a median time from diagnosis to study inclusion of 16 hours. The study focused on treating ARDS, analyzing the severity and duration of the condition as factors in the treatment analysis.\",32\n145,SOFA SCORE,\"The Sequential Organ Failure Assessment (SOFA) score is a comprehensive scoring system used to track a patient's status, particularly focusing on organ function and the rate of organ failure. It is primarily utilized during a patient's stay in an intensive care unit (ICU) to assess the extent of organ dysfunction. The SOFA score is also employed in clinical trials and studies to define and monitor organ-system failure, providing critical insights into a patient's condition during treatment.\",8\n89,CISATRACURIUM,\"Cisatracurium is a neuromuscular blocking agent used in the ROSE trial as part of the intervention group for patients with Acute Respiratory Distress Syndrome (ARDS). The study aimed to evaluate the effect of Cisatracurium on 90-day mortality in patients, comparing its use to a placebo group. It is administered as an early continuous infusion in ARDS patients to improve survival rates and reduce barotrauma. However, there was one death in the trial that was possibly related to the use of Cisatracurium.\",13\n579,PRONE POSITIONING,\"Prone positioning is a medical intervention where patients are placed face down to improve oxygenation and reduce lung injury in patients with Acute Respiratory Distress Syndrome (ARDS). This technique is used to enhance outcomes in patients with severe ARDS by positioning them face down, which has been shown to be beneficial in clinical studies.\",6\n202,INTERVENTION GROUP,The INTERVENTION GROUP refers to the group of patients in the study who received a cisatracurium infusion and were under deeper sedation during the 48-hour intervention period.,8\n190,ROSE TRIAL,\"The Reevaluation of Systemic Early Neuromuscular Blockade (ROSE) trial is a multicenter, unblinded, randomized trial conducted by the PETAL Clinical Trials Network to assess the efficacy and safety of early neuromuscular blockade in ARDS patients\",5\n204,PEEP,Positive End-Expiratory Pressure (PEEP) is a ventilation parameter that was measured in the study and used as a strategy in the trial to reduce mortality among patients with Acute Respiratory Distress Syndrome (ARDS).,2\n206,PAO2:FIO2,The PAO2:FIO2 ratio is a metric used to assess the oxygenation status of patients in the study.,2\n576,SUPINE POSITIONING,\"Supine positioning is a medical intervention that involves placing patients on their back. It is commonly used as a control position in studies, particularly those comparing it with prone positioning. In the context of the study mentioned, supine positioning serves as a standard method for positioning patients on their backs.\",2\n208,ACURASYS,ACURASYS is a previous multicenter trial that showed a benefit with early continuous neuromuscular blockade in patients with ARDS,1\n592,ALMITRINE BISMESYLATE,Almitrine bismesylate is a drug used in the study as an adjunctive therapy to improve oxygenation,1\n578,AMERICAN–EUROPEAN CONSENSUS CONFERENCE,A conference that established criteria for defining ARDS,1\n200,ICU MOBILITY SCALE,A scale used to assess limitations on physical activity in the trial,1\n201,BRICE QUESTIONNAIRE,A modified questionnaire used to assess recall of paralysis in the trial,1\n209,HISPANIC ETHNIC GROUP,A demographic group mentioned in the context of treatment interaction in the trial,1\n211,NEUROMUSCULAR BLOCKADE,\"A medical procedure involving the use of drugs to block neuromuscular transmission, used in the trial for ARDS patients\",1\n212,PEEP STRATEGY,Positive End-Expiratory Pressure strategy used in the treatment of ARDS to improve oxygenation,1\n585,INFLUENZA A (H1N1),A virus infection that was the main cause of ARDS in 28 patients in the study,1\n594,H1N1 VIRUS,,1\n590,ECMO,\"Extracorporeal Membrane Oxygenation, a rescue therapy used in the study for patients with severe respiratory failure\",1\n591,INHALED NITRIC OXIDE,Inhaled nitric oxide is a therapy used in the study to improve oxygenation in patients,1\n593,NEUROMUSCULAR BLOCKERS,Neuromuscular blockers are medications used in the study to facilitate mechanical ventilation,1\n598,HYPOXEMIA,,1\n96,EUROPEAN EPIDEMIOLOGIC STUDY,The EUROPEAN EPIDEMIOLOGIC STUDY is a research initiative that provided crucial data for the sample-size calculation in a trial.,2\n94,CHI-SQUARE TEST,The Chi-square test is a statistical test used to determine if there is a significant association between two categorical variables in a study. It is employed to compare categorical variables between two groups and to assess interactions between study groups and interventions.,4\n92,STUDENT'S T-TEST,Student's t-test is a statistical test used in the study to compare the means of two groups. It is specifically employed to compare baseline variables and assess differences between the two groups at the baseline stage.,4\n207,SOFA SCORES,Sequential Organ Failure Assessment scores used to evaluate organ function in patients,2\n88,ACUTE LUNG INJURY VERIFICATION (ALIVE),The Acute Lung Injury Verification (ALIVE) is a European epidemiologic study that provides data for assumptions in sample-size calculations for clinical trials.,2\n90,SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS) II,\"The Simplified Acute Physiology Score (SAPS) II is a scoring system designed to assess the severity of a patient's condition in intensive care units. It is calculated from 12 physiological measurements, previous health status, and admission information, with scores ranging from 0 to 163. This comprehensive scoring system helps in evaluating disease severity, aiding healthcare professionals in making informed decisions regarding patient care.\",2\n93,WILCOXON TEST,The Wilcoxon test is a non-parametric statistical test used to compare two paired groups in the study.,1\n210,TRIAL SITES,Locations where the clinical trial was conducted,1\n10,NEJM,\"The New England Journal of Medicine (NEJM) is a prestigious medical journal known for publishing significant medical studies. The full text of articles, including the study in question, is available on their website, NEJM.org. Additionally, the journal is a platform where important documents such as the protocol and statistical analysis plan for studies are published, ensuring comprehensive access to critical research information.\",3\n205,FIO2,\"Fraction of Inspired Oxygen, a parameter measured in the study to assess oxygenation\",1\n191,ACURASYS TRIAL,\"The ACURASYS TRIAL, also known as the ARDS et Curarisation Systematique trial, was a large multicenter clinical trial conducted a decade ago. It investigated the effects of early neuromuscular blockade in patients with Acute Respiratory Distress Syndrome (ARDS). The trial specifically utilized the neuromuscular blocking agent cisatracurium, following a particular dosing regimen and duration of treatment.\",3\n596,ALVEOLAR RECRUITMENT,\"The process of opening collapsed alveoli in the lungs to improve gas exchange, enhanced by prone positioning\",1\n428,BASELINE VARIABLES,,2\n595,VENTILATOR-INDUCED LUNG INJURY,\"Lung damage that can occur from mechanical ventilation, which prone positioning aims to prevent\",1\n540,WILCOXON'S RANK-SUM TEST,Wilcoxon's rank-sum test is a non-parametric statistical test used in the study to compare differences between two groups,2\n192,PETAL CLINICAL TRIALS NETWORK,\"The Prevention and Early Treatment of Acute Lung Injury (PETAL) Clinical Trials Network is part of the National Heart, Lung, and Blood Institute, responsible for conducting the ROSE trial\",1\n624,SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA) SCORE,The Sequential Organ Failure Assessment (SOFA) score is used to track a patient's status during their stay in an intensive care unit,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n309,ICU,ARDS,\"Intensive Care Units (ICUs) are specialized hospital departments that provide critical care for patients with severe medical conditions, including Acute Respiratory Distress Syndrome (ARDS). Patients with severe ARDS are treated in the ICU, where they receive comprehensive care and interventions such as prone positioning to improve their respiratory function and overall outcomes.\",78\n152,SEPTIC SHOCK,SOFA SCORE,The SOFA score is used to predict the likelihood of developing septic shock,78\n308,ICU,CISATRACURIUM,Cisatracurium was administered to patients in 20 multidisciplinary ICUs following international standards of care,59\n566,SOFA SCORE,EGDT,The SOFA score was used to assess patients in the EGDT group,59\n331,ICU,SOFA SCORE,The SOFA score is used to assess organ dysfunction in patients in the ICU,54\n339,ICU,PRONE POSITIONING,ICUs are skilled in performing prone positioning on patients with ARDS,52\n273,PLACEBO GROUP,CISATRACURIUM,The study compares the effects of cisatracurium on 90-day mortality against a placebo group,48\n487,TRIAL,INTERVENTION GROUP,The intervention group was part of the trial studying ARDS treatment,48\n393,ARDS,CONTROL GROUP,The control group was part of a study focusing on treatment for patients with ARDS,46\n376,CISATRACURIUM,ARDS,\"Cisatracurium is a medication used in the management of patients with severe Acute Respiratory Distress Syndrome (ARDS). It has been employed in clinical trials to assess its effectiveness in improving outcomes for these patients. The trials specifically aimed to evaluate the impact of cisatracurium on 90-day mortality rates among ARDS patients. While the medication was generally used to manage ARDS, there was an instance in the trial where one death was possibly related to its use. Overall, cisatracurium's role in the treatment of ARDS is being studied to determine its potential benefits and risks.\",45\n400,ARDS,HFOV,High-Frequency Oscillatory Ventilation (HFOV) is a ventilation strategy employed in the treatment of Acute Respiratory Distress Syndrome (ARDS). It is specifically used as a treatment strategy for managing ARDS in adults.,44\n233,UNITED STATES,ARDS,The trial studying ARDS was conducted in the United States,43\n263,HOSPITAL,ARDS,Patients with ARDS are treated in hospitals,41\n389,ARDS,SOFA SCORE,The SOFA score is a tool used to assess the severity of organ failure and organ dysfunction in patients with Acute Respiratory Distress Syndrome (ARDS).,40\n392,ARDS,INTERVENTION GROUP,The intervention group was part of a study focusing on treatment for patients with ARDS,40\n387,ARDS,MECHANICAL VENTILATION,Mechanical ventilation is used in the treatment of ARDS to assist with breathing,39\n401,ARDS,PROSEVA,The PROSEVA trial focused on the effects of prone positioning in patients with ARDS,39\n388,ARDS,INTENSIVE CARE UNIT,Patients with ARDS are often treated in the Intensive Care Unit,38\n402,ARDS,PRONE POSITIONING,Prone positioning is a treatment method used to improve outcomes in patients with Acute Respiratory Distress Syndrome (ARDS). It is particularly beneficial in enhancing oxygenation and has been shown to improve survival rates in patients with severe ARDS.,38\n386,ARDS,ROSE TRIAL,The ROSE trial investigated the efficacy and safety of early neuromuscular blockade in patients with ARDS,37\n395,ARDS,PEEP,PEEP was used as a strategy in the trial to reduce mortality in patients with ARDS,34\n397,ARDS,PAO2:FIO2,The Pao2:Fio2 ratio is used to evaluate the severity of ARDS in patients,34\n403,ARDS,SUPINE POSITIONING,\"Supine positioning is primarily used as a control in studies to compare its effects with prone positioning in patients with Acute Respiratory Distress Syndrome (ARDS). While it is occasionally mentioned as a treatment method in studies involving ARDS patients, its main role is to serve as a baseline or standard position against which the benefits of prone positioning can be evaluated.\",34\n411,ARDS,VASOPRESSORS,Vasopressors were used to support blood pressure in patients with ARDS,34\n413,ARDS,CATECHOLAMINES,Catecholamines are used in the treatment of ARDS to support cardiovascular function,34\n394,ARDS,ACURASYS,The ACURASYS trial focused on the treatment of ARDS using early continuous neuromuscular blockade,33\n409,ARDS,ALMITRINE BISMESYLATE,Almitrine bismesylate was used as an adjunctive therapy to improve oxygenation in patients with ARDS,33\n404,ARDS,AMERICAN–EUROPEAN CONSENSUS CONFERENCE,The conference established criteria for defining ARDS,33\n390,ARDS,ICU MOBILITY SCALE,The ICU Mobility Scale was used to assess physical activity limitations in patients with ARDS,33\n391,ARDS,BRICE QUESTIONNAIRE,The Brice Questionnaire was used to assess recall of paralysis in patients with ARDS,33\n396,ARDS,HISPANIC ETHNIC GROUP,The trial noted an unexpected interaction between the Hispanic ethnic group and treatment for ARDS,33\n398,ARDS,NEUROMUSCULAR BLOCKADE,Neuromuscular blockade was used as a treatment method in the trial for ARDS patients,33\n399,ARDS,PEEP STRATEGY,The PEEP strategy was employed in the treatment of ARDS to improve patient outcomes,33\n405,ARDS,INFLUENZA A (H1N1),Influenza A (H1N1) was a main cause of ARDS in the study,33\n406,ARDS,H1N1 VIRUS,\"The study involved patients with ARDS, some of whom received antiviral therapy for H1N1 virus infection\",33\n407,ARDS,ECMO,ECMO was used as a rescue therapy for patients with severe ARDS in the study,33\n408,ARDS,INHALED NITRIC OXIDE,Inhaled nitric oxide was used to improve oxygenation in patients with ARDS in the study,33\n410,ARDS,NEUROMUSCULAR BLOCKERS,Neuromuscular blockers were used to facilitate mechanical ventilation in patients with ARDS,33\n412,ARDS,HYPOXEMIA,Hypoxemia is a common symptom in patients suffering from ARDS,33\n381,CISATRACURIUM,MULTICENTER TRIAL,The multicenter trial evaluated the effectiveness of cisatracurium in treating severe ARDS,29\n567,SOFA SCORE,USUAL-CARE GROUP,The SOFA score was used to assess patients in the usual-care group,26\n555,SEVERE SEPSIS,SOFA SCORE,The SOFA score is used to assess organ function in patients with severe sepsis,25\n631,INTERVENTION GROUP,CONTROL GROUP,The study involved a comparison between the INTERVENTION GROUP and the CONTROL GROUP to assess the effects of different treatments on patients with Acute Respiratory Distress Syndrome (ARDS). The trial specifically focused on comparing outcomes between these two groups to evaluate the efficacy of the interventions.,22\n383,CISATRACURIUM,INTERVENTION GROUP,Cisatracurium was administered to patients in the intervention group,21\n380,CISATRACURIUM,FISHER'S EXACT TEST,Fisher's exact test was used to assess differences between the cisatracurium and placebo groups,18\n382,CISATRACURIUM,ROSE TRIAL,Cisatracurium was used as the neuromuscular blocking agent in the ROSE trial,18\n423,EUROPEAN EPIDEMIOLOGIC STUDY,MULTICENTER TRIAL,The European epidemiologic study provided data for the sample-size calculation in the multicenter trial,18\n379,CISATRACURIUM,CHI-SQUARE TEST,The chi-square test was used to assess differences between the cisatracurium and placebo groups,17\n377,CISATRACURIUM,STUDENT'S T-TEST,Student's t-test was used to assess differences between the cisatracurium and placebo groups,17\n613,\"NATIONAL HEART, LUNG, AND BLOOD INSTITUTE\",ROSE TRIAL,\"The National Heart, Lung, and Blood Institute funded the ROSE trial\",17\n636,CONTROL GROUP,SOFA SCORES,SOFA scores were used to evaluate organ function in the control group,16\n373,ACUTE LUNG INJURY VERIFICATION (ALIVE),CISATRACURIUM,The ALIVE study provided data for assumptions in the sample-size calculation for the cisatracurium study,15\n375,CISATRACURIUM,SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS) II,SAPS II was used as a covariate in the Cox regression model to evaluate the effect of cisatracurium on 90-day mortality,15\n568,SOFA SCORE,SEPSIS STUDY,The SOFA score was used to define organ-system failure in the study,15\n378,CISATRACURIUM,WILCOXON TEST,The Wilcoxon test was used to assess differences between the cisatracurium and placebo groups,14\n384,CISATRACURIUM,TRIAL SITES,Trial sites were locations where Cisatracurium was administered to patients,14\n417,CHI-SQUARE TEST,STUDY GROUP,Chi-square test was used to determine interactions between study groups and interventions,13\n569,SOFA SCORE,HYDROCORTISONE-PLUS-FLUDROCORTISONE TRIAL,The trial measured the time to reach a SOFA score below 6 as an outcome,12\n22,ELI LILLY,NEJM,The full text of the study sponsored by Eli Lilly is available on NEJM.org,11\n632,INTERVENTION GROUP,PEEP,The intervention group had lower PEEP requirements compared to the control group,10\n634,INTERVENTION GROUP,PAO2:FIO2,The Pao2:Fio2 ratio was measured to assess oxygenation in the intervention group,10\n635,INTERVENTION GROUP,SOFA SCORES,SOFA scores were used to evaluate organ function in the intervention group,10\n633,INTERVENTION GROUP,FIO2,The intervention group had lower Fio2 requirements compared to the control group,9\n43,NEJM,PRONE POSITIONING,The study on prone positioning in ARDS patients was published in the New England Journal of Medicine,9\n623,ACURASYS TRIAL,NHLBI,The ACURASYS trial's protocol was overseen by the NHLBI,8\n621,ROSE TRIAL,ACURASYS TRIAL,The ROSE trial was designed to be consistent with certain elements of the ACURASYS trial,8\n415,STUDENT'S T-TEST,CHI-SQUARE TEST,Both are statistical tests used in the study to compare baseline characteristics between groups,8\n1004,SUPINE POSITIONING,PRONE POSITIONING,The study compares the effects of prone positioning versus supine positioning on patient outcomes,8\n1007,PRONE POSITIONING,ALVEOLAR RECRUITMENT,\"Prone positioning promotes alveolar recruitment, improving lung function in ARDS patients\",7\n420,FISHER'S EXACT TEST,BASELINE VARIABLES,Fisher's exact test was used to compare baseline variables in the study,7\n1006,PRONE POSITIONING,VENTILATOR-INDUCED LUNG INJURY,Prone positioning helps prevent ventilator-induced lung injury in ARDS patients,7\n42,NEJM,ACURASYS TRIAL,The protocol and statistical analysis plan of the ACURASYS trial were published in NEJM,6\n414,STUDENT'S T-TEST,BASELINE VARIABLES,Student's t-test was used to compare baseline variables in the study,6\n418,CHI-SQUARE TEST,WILCOXON'S RANK-SUM TEST,Both are statistical tests used in the study to compare differences between groups,6\n622,ROSE TRIAL,PETAL CLINICAL TRIALS NETWORK,The PETAL Clinical Trials Network conducted the ROSE trial,6\n416,STUDENT'S T-TEST,WILCOXON'S RANK-SUM TEST,Both are statistical tests used in the study to compare differences between groups,6\n374,ACUTE LUNG INJURY VERIFICATION (ALIVE),EUROPEAN EPIDEMIOLOGIC STUDY,\"The European epidemiologic study includes the Acute Lung Injury Verification (ALIVE) study, which provides data for clinical research\",4\n385,SIMPLIFIED ACUTE PHYSIOLOGY SCORE (SAPS) II,SEQUENTIAL ORGAN FAILURE ASSESSMENT (SOFA) SCORE,Both the SAPS II and SOFA score were used to assess the severity of illness in patients,3\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}